Related Experiment Videos
[Hypokalemic thyrotoxic periodic paralysis: a case report].
F Vandergheynst1, A Vandergheynst, A Leleux
1Service de Médecine Interne, C.H.U. Tivoli, La Louviere.
Acta Clinica Belgica
|May 23, 2002
Summary
Hypokalemic thyrotoxic periodic paralysis, a rare condition in Caucasian men, causes intermittent muscle weakness due to hyperthyroidism. Prompt treatment with potassium and propranolol effectively resolves and prevents episodes.
Area of Science:
- Endocrinology
- Neurology
- Internal Medicine
Background:
- Hyperthyroidism, particularly Basedow's disease, can manifest with rare neuromuscular complications.
- Thyrotoxic periodic paralysis is a condition characterized by episodic muscle weakness linked to low serum potassium levels.
Observation:
- A 25-year-old Caucasian male presented with severe hyperthyroidism and recurrent proximal lower limb muscle paresis.
- During episodes, serum potassium levels dropped significantly (e.g., from 4.1 to 2.9 meq/l).
Findings:
- The patient was diagnosed with hypokalemic thyrotoxic periodic paralysis, a condition significantly more prevalent in Asiatic populations.
- The pathophysiology involves intracellular potassium shifts, potentially mediated by Na/K ATP-ases, which are upregulated in hyperthyroidism.
Implications:
- Early diagnosis and management of hyperthyroidism are crucial for preventing paralytic episodes.
- Intravenous potassium administration and beta-blockers like propranolol are effective in acute management and prevention of recurrent paralysis.